Literature DB >> 32263126

Single step synthesis of carbon dot embedded chitosan nanoparticles for cell imaging and hydrophobic drug delivery.

Angshuman Ray Chowdhuri1, Satyajit Tripathy, Chanchal Haldar, Somenath Roy, Sumanta Kumar Sahu.   

Abstract

The florescent carbon dot conjugated chitosan nanoparticles are developed for the cellular imaging and delivery of poorly water soluble drug telmisartan (TEL). In this work, the florescent chitosan nanoparticles are synthesized in a single step. The presence of surface functional groups and conjugation of the nanoparticles are investigated by FTIR spectroscopy. Dynamic light scattering and TEM analysis are performed to determine the size of the nanoparticles. To investigate the surface morphology FESEM analysis is also performed. The cytotoxicity of the nanoparticles is examined by MTT assay using normal lymphocytes and KG1A cancer cell lines. The intracellular cellular uptake is studied by fluorescence microscopy and flow cytometry analysis. The interactions between the nanoparticles and the drug are investigated by Gaussian 09 and visualized by GaussView 5 program package.

Entities:  

Year:  2015        PMID: 32263126     DOI: 10.1039/c5tb01831e

Source DB:  PubMed          Journal:  J Mater Chem B        ISSN: 2050-750X            Impact factor:   6.331


  3 in total

1.  Luminescent chitosan/carbon dots as an effective nano-drug carrier for neurodegenerative diseases.

Authors:  Sheril Ann Mathew; P Praveena; S Dhanavel; R Manikandan; S Senthilkumar; A Stephen
Journal:  RSC Adv       Date:  2020-06-25       Impact factor: 4.036

Review 2.  Natural carbon-based quantum dots and their applications in drug delivery: A review.

Authors:  Akhila Nair; Jozef T Haponiuk; Sabu Thomas; Sreeraj Gopi
Journal:  Biomed Pharmacother       Date:  2020-10-06       Impact factor: 6.529

3.  Dansyl-modified carbon dots with dual-emission for pH sensing, Fe3+ ion detection and fluorescent ink.

Authors:  Hua Tian; Yongcheng Dai; Wenzhe Fu; Haifang Liu; Mengting Li; Meiyuan Lv; Xueqiong Yin
Journal:  RSC Adv       Date:  2020-10-07       Impact factor: 4.036

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.